Clinical Trial Update: The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of benzalkonium chloride (BAK) on the blood-aqueous barrier in pseudophakic patients with dry eye disease has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Benzalkonium chloride (benzalkonium chloride)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2012-07-12